Literature DB >> 19332245

Surgical management of recurrent ovarian cancer.

Mario M Leitao1, Dennis S Chi.   

Abstract

Surgery is the cornerstone of treatment for patients with advanced ovarian cancer. The majority of patients with advanced ovarian cancer who experience a clinical remission after initial surgery will develop a recurrence. The optimal management for patients with recurrent ovarian cancer remains to be defined. Chemotherapy is frequently used with varying response rates. Repeat surgical cytoreduction appears to offer a survival benefit for select patients with recurrent ovarian cancer and should be considered. Surgery also plays a role in the palliation of certain patients. Continued investigations, especially randomized trials, are needed to further define the optimal treatment modalities for these patients.

Entities:  

Mesh:

Year:  2009        PMID: 19332245     DOI: 10.1053/j.seminoncol.2008.12.002

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  21 in total

Review 1.  Overcoming challenges of ovarian cancer stem cells: novel therapeutic approaches.

Authors:  Cristóbal Aguilar-Gallardo; Emily Cecilia Rutledge; Ana M Martínez-Arroyo; Juan José Hidalgo; Santiago Domingo; Carlos Simón
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

Review 2.  The role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of ovarian cancer relapse.

Authors:  E Saladino; F Fleres; S Irato; C Famulari; A Macrì
Journal:  Updates Surg       Date:  2013-08-27

3.  Prognostic factors of secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer.

Authors:  Kidong Kim; Sang-Young Ryu
Journal:  J Gynecol Oncol       Date:  2009-09-30       Impact factor: 4.401

Review 4.  Ovarian cancer stem cells: Can targeted therapy lead to improved progression-free survival?

Authors:  Christen L Walters Haygood; Rebecca C Arend; J Michael Straughn; Donald J Buchsbaum
Journal:  World J Stem Cells       Date:  2014-09-26       Impact factor: 5.326

5.  Ovarian cancer recurrence update.

Authors:  Stefano Cianci
Journal:  Gland Surg       Date:  2020-08

6.  Potential clinical application of tumor-infiltrating lymphocyte therapy for ovarian epithelial cancer prior or post-resistance to chemotherapy.

Authors:  Donastas Sakellariou-Thompson; Marie-Andrée Forget; Emily Hinchcliff; Joseph Celestino; Patrick Hwu; Amir A Jazaeri; Cara Haymaker; Chantale Bernatchez
Journal:  Cancer Immunol Immunother       Date:  2019-10-10       Impact factor: 6.968

7.  Cytoreductive Surgery and Intraperitoneal Chemotherapy in Advanced Serous Epithelial Ovarian Cancer: A 14-Year French Retrospective Single-Center Study of 124 Patients.

Authors:  Brice Paquette; Elsa Kalbacher; Frédéric Mercier; Zaher Lakkis; Alexandre Doussot; Célia Turco; Edda Caputo; Sébastien Pili-Floury; Bernard Royer; Laura Mansi; Delphine Delroeux; Martin Demarchi; Xavier Pivot; Bruno Chauffert; Elise Clement; Bruno Heyd
Journal:  Ann Surg Oncol       Date:  2022-01-07       Impact factor: 5.344

8.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in recurrent ovarian cancer with peritoneal metastasis: a prospective registry study on 41 patients.

Authors:  Melissa Ching Ching Teo; Claramae Shulyn Chia; Cindy Lim; Grace Hwei Ching Tan; Whay Kuang Chia; Khee Chee Soo
Journal:  Pleura Peritoneum       Date:  2017-12-01

9.  Hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer recurrence: systematic review and meta-analysis.

Authors:  Stefano Cianci; Gaetano Riemma; Carlo Ronsini; Pasquale De Franciscis; Marco Torella; Antonio Schiattarella; Marco La Verde; Nicola Colacurci
Journal:  Gland Surg       Date:  2020-08

10.  Predictors of morbidity and mortality in patients submitted to cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for ovarian carcinomatosis: a multicenter study.

Authors:  Antonio Macrì; Fabio Accarpio; Vincenzo Arcoraci; Francesco Casella; Franco De Cian; Pierandrea De Iaco; Elena Orsenigo; Franco Roviello; Giovanni Scambia; Edoardo Saladino; Marica Galati
Journal:  Pleura Peritoneum       Date:  2020-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.